Board
By letter dated 28 September 2026, we informed you of the candidates proposed by the current Board of the GDCh Division of Medicinal Chemistry for the forthcoming Board election. No further nominations were submitted by members. Accordingly, the Board election will be held with the following candidates, all of whom have agreed to stand.
University/research institution/authority
| Name | Affiliation | Election status |
| Prof. Dr. Matthias Gehringer | Eberhard Karls University of Tübingen | New election |
| Prof. Dr. Daniel Merk | Ludwig Maximilian University of Munich | New election |
| Prof. Dr. Holger Stark | Heinrich Heine University Düsseldorf | Re-election |
Industry/self-employed professionals
| Name | Affiliation | Election status |
| Dr. Stefanie Flohr | Novartis AG, Basel (Switzerland) | New election |
| Dr. Felix Pape | Nuvisan Pharma Services Group, Berlin | New election |
| Dr. Tatjana Ross | Merck KGaA, Darmstadt | Re-election |
According to the Division's bylaws, the Board comprises a maximum of six members (1 Chair, 1 Deputy Chair and up to 4 other members), each elected for a term of four years. Universities and industry should be represented equally on the Board. Re-election is permitted once. Thus, six candidates are standing for the six Board positions to be filled. The Chair will be chosen from among the elected Board members after the election.
The election results will be announced in Nachrichten aus der Chemie and on the Division's website.

In a letter dated 28 September 2026, we informed you of the candidates proposed by the incumbent Board of the GDCh Division of Medicinal Chemistry for the forthcoming Board election. No further nominations were submitted by members. Accordingly, the Board election will be held with the following candidates, all of whom have agreed to stand.
University/research institution/authority
| Name | Affiliation | Election status |
| Prof. Dr. Matthias Gehringer | Eberhard Karls University of Tübingen | New election |
| Prof. Dr. Daniel Merk | Ludwig Maximilian University of Munich | New election |
| Prof. Dr. Holger Stark | Heinrich Heine University Düsseldorf | Re-election |
Industry/self-employed professionals
| Name | Affiliation | Election status |
| Dr. Stefanie Flohr | Novartis AG, Basel (Switzerland) | New election |
| Dr. Felix Pape | Nuvisan Pharma Services Group, Berlin | New election |
| Dr. Tatjana Ross | Merck KGaA, Darmstadt | Re-election |
According to the Division's bylaws, the Board consists of a maximum of six members (1 Chair, 1 Deputy Chair, and up to 4 members), each elected for a term of four years. Universities and industry should be equally represented on the Board. One re-election is permitted. Thus, six candidates are standing for the six Board positions to be filled. The Chair will be selected from among the elected Board members after the election.
The election results will be announced in Nachrichten aus der Chemie and on the Division's website.

The term of office of the Board of the GDCh Division of Medicinal Chemistry ends on 31 December 2026, and you, as members of the Division, are invited to nominate candidates for the Board election who
Under the Division’s bylaws, the Board consists of a maximum of six members (1 Chair, 1 Deputy Chair and a maximum of 4 ordinary members), each elected for a term of four years. Universities and industry should be represented equally on the Board. Members may be re-elected once.
After serving two terms, Prof. Dr. Christian Ducho, Dr. Gerhard Heßler and Prof. Dr. Anna Hirsch are no longer eligible to stand for a further term. Unfortunately, Dr. Christian Kuttruff is not available for a further term of office. Dr. Tatjana Ross and Prof. Dr. Holger Stark have indicated that they are willing to stand for re-election. We would like to take this opportunity to thank them all for their many years of successful service to the Division and the GDCh as a whole.
For the six Board positions up for election, the current Board is putting forward the following six candidates, in addition to your nominations:
University/research institution/authority
| Name | Affiliation | Election status |
| Prof. Dr. Matthias Gehringer | Eberhard Karls University of Tübingen | New election |
| Prof. Dr. Daniel Merk | Ludwig Maximilian University of Munich | New election |
| Prof. Dr. Holger Stark | Heinrich Heine University Düsseldorf | Re-election |
Industry/self-employed professions
| Name | Affiliation | Election status |
| Dr. Stefanie Flohr | Novartis AG, Basel (Switzerland) | New election |
| Dr. Felix Pape | Nuvisan Pharma Services Group, Berlin | New election |
| Dr. Tatjana Ross | Merck KGaA, Darmstadt | Re-election |
If no written proposals to nominate additional candidates are received by the GDCh Office (for the attention of Maike Fries; m.fries@gdch.de) by 16 October 2026, the election will be held Online from 2 November 2026 with the candidates listed above.